360 High-Risk Vulnerability Immunization Tool V2.0 vs CrowdStrike Endpoint Security: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

CrowdStrike Endpoint Security: AI-powered endpoint protection, detection, and response platform. built by CrowdStrike. Core capabilities include AI-powered endpoint protection with 100% protection scores in MITRE ATT&CK 2025 evaluations, Single lightweight sensor deployment across all major operating systems, Charlotte AI for automated detection triage, investigation, and response..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. CrowdStrike Endpoint Security differentiates with AI-powered endpoint protection with 100% protection scores in MITRE ATT&CK 2025 evaluations, Single lightweight sensor deployment across all major operating systems, Charlotte AI for automated detection triage, investigation, and response.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). CrowdStrike Endpoint Security is developed by CrowdStrike. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and CrowdStrike Endpoint Security serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.